AI-enabled drug discovery Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
09:46
Jan 22
Brett Winton Chief Futurist, ARK Invest Bloomberg Markets
AI lowers drug costs, lifting biotech.
AI will decrease the costs to deliver drugs to market and increase returns on R&D, benefiting drug discovery and biotechnology over the second half of the decade, although progress can be volatile with three steps forward and one step back.
MED

About AI-enabled drug discovery Investor Commentary

Across the available history and selected sources, Buzzberg tracks AI-enabled drug discovery across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Brett Winton.